Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 651–700 of 807 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03377400	Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer	unknown	Phase 2	40	Samsung Medical CenterOTHER	1	Dec 17, 2020	clinicaltrials
NCT03987815	Neoadjuvant Nivolumab for Operable Esophageal Carcinoma	unknown	Phase 2	20	Samsung Medical CenterOTHER	1	Dec 17, 2020	clinicaltrials
NCT02890979